FA First Advantage | $16.41
+5.9% | 4/23/2024 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of First Advantage (NYSE:FA) on 4/23/2024 |
CCL Carnival Co. & | $14.79
+3.6% | 4/22/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Carnival Co. & (NYSE:CCL) on 4/22/2024 |
MRUS Merus | $40.82
+0.9% | 4/22/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Merus (NASDAQ:MRUS) on 4/22/2024 |
CXM Sprinklr | $11.83
+3.1% | 4/22/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Sprinklr (NYSE:CXM) on 4/22/2024 |
ONON ON | $32.54
+1.9% | 4/16/2024 | Initiated by | William Blair | Analyst D. Carden | Outperform | | Low | View details for William Blair rating of ON (NYSE:ONON) on 4/16/2024 |
SNPO Snap One | $10.56
+0.2% | 4/15/2024 | Downgraded by | William Blair | Analyst R. Merkel | Outperform -> Market Perform | | Low | View details for William Blair rating of Snap One (NASDAQ:SNPO) on 4/15/2024 |
|
CGEM Cullinan Oncology | $16.67
+6.7% | 4/15/2024 | Initiated by | William Blair | Analyst M. Phipps | Outperform | | Low | View details for William Blair rating of Cullinan Oncology (NASDAQ:CGEM) on 4/15/2024 |
LENZ LENZ Therapeutics | $15.92
+0.2% | 4/15/2024 | Initiated by | William Blair | Analyst T. Lugo | Outperform | | Low | View details for William Blair rating of LENZ Therapeutics (NASDAQ:LENZ) on 4/15/2024 |
NMRA Neumora Therapeutics | $10.30
-1.1% | 4/12/2024 | Reiterated by | William Blair | Analyst M. Minter | Outperform | | Low | View details for William Blair rating of Neumora Therapeutics (NASDAQ:NMRA) on 4/12/2024 |
VITL Vital Farms | $26.25
+3.6% | 4/10/2024 | Initiated by | William Blair | Analyst J. Andersen | Outperform | | Low | View details for William Blair rating of Vital Farms (NASDAQ:VITL) on 4/10/2024 |
IDXX IDEXX Laboratories | $493.80
+3.0% | 4/9/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of IDEXX Laboratories (NASDAQ:IDXX) on 4/9/2024 |
IONS Ionis Pharmaceuticals | $41.84
+1.9% | 4/9/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/9/2024 |
TW Tradeweb Markets | $101.83
+0.2% | 4/9/2024 | Initiated by | William Blair | Analyst J. Schmitt | Outperform | | N/A | View details for William Blair rating of Tradeweb Markets (NASDAQ:TW) on 4/9/2024 |
ALNY Alnylam Pharmaceuticals | $146.07
+0.2% | 4/8/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 4/8/2024 |
PNST Pinstripes | $3.01
+9.5% | 4/8/2024 | Initiated by | William Blair | Analyst S. Zackfia | Outperform | | Low | View details for William Blair rating of Pinstripes (NYSE:PNST) on 4/8/2024 |
STAA STAAR Surgical | $48.19
+3.5% | 4/4/2024 | Upgraded by | William Blair | Analyst M. Kaczor | Market Perform -> Outperform | | Low | View details for William Blair rating of STAAR Surgical (NASDAQ:STAA) on 4/4/2024 |
KRUS Kura Sushi USA | $111.76
+1.7% | 4/5/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Kura Sushi USA (NASDAQ:KRUS) on 4/5/2024 |
PWFL PowerFleet | $4.19
+3.2% | 4/3/2024 | Initiated by | William Blair | Analyst D. Becker | Outperform | | Low | View details for William Blair rating of PowerFleet (NASDAQ:PWFL) on 4/3/2024 |
KVUE Kenvue | $19.36
-1.1% | 4/3/2024 | Initiated by | William Blair | Analyst J. Andersen | Market Perform | | Low | View details for William Blair rating of Kenvue (NYSE:KVUE) on 4/3/2024 |
DSG The Descartes Systems Group | C$128.51
+2.4% | 4/1/2024 | Reiterated by | William Blair | Analyst D. Becker | Outperform | | N/A | View details for William Blair rating of The Descartes Systems Group (TSE:DSG) on 4/1/2024 |
NVEI Nuvei | $32.08
-0.1% | 4/1/2024 | Downgraded by | William Blair | Analyst C. Kennedy | Outperform -> Market Perform | | Low | View details for William Blair rating of Nuvei (NASDAQ:NVEI) on 4/1/2024 |
DSGX The Descartes Systems Group | $94.10
+2.7% | 4/1/2024 | Reiterated by | William Blair | Analyst D. Becker | Outperform | | Low | View details for William Blair rating of The Descartes Systems Group (NASDAQ:DSGX) on 4/1/2024 |
AXDX Accelerate Diagnostics | $0.95
+6.7% | 4/2/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Accelerate Diagnostics (NASDAQ:AXDX) on 4/2/2024 |
BIIB Biogen | $193.18
-0.5% | 4/1/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Biogen (NASDAQ:BIIB) on 4/1/2024 |
BMY Bristol-Myers Squibb | $49.00
-0.3% | 4/1/2024 | Reiterated by | William Blair | Analyst M. Phipps | Market Perform | | Low | View details for William Blair rating of Bristol-Myers Squibb (NYSE:BMY) on 4/1/2024 |
MRNA Moderna | $107.89
+3.3% | 4/1/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Moderna (NASDAQ:MRNA) on 4/1/2024 |
PIII P3 Health Partners | $0.51
-1.9% | 4/1/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of P3 Health Partners (NASDAQ:PIII) on 4/1/2024 |
BSY Bentley Systems | $54.42
+2.3% | 3/28/2024 | Initiated by | William Blair | Analyst D. Becker | Outperform | | Low | View details for William Blair rating of Bentley Systems (NASDAQ:BSY) on 3/28/2024 |
SLDB Solid Biosciences | $9.11
+0.8% | 3/28/2024 | Reiterated by | William Blair | Analyst T. Lugo | Outperform | | Low | View details for William Blair rating of Solid Biosciences (NASDAQ:SLDB) on 3/28/2024 |
BRZE Braze | $40.79
+2.8% | 3/28/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Braze (NASDAQ:BRZE) on 3/28/2024 |
CXM Sprinklr | $11.83
+3.1% | 3/28/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
ENV Envestnet | $62.50
+1.3% | 3/27/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Envestnet (NYSE:ENV) on 3/27/2024 |
NCNO nCino | $30.16
+1.8% | 3/27/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of nCino (NASDAQ:NCNO) on 3/27/2024 |
REKR Rekor Systems | $1.84
+2.8% | 3/26/2024 | Reiterated by | William Blair | Analyst L. Dipalma | Outperform | | Low | View details for William Blair rating of Rekor Systems (NASDAQ:REKR) on 3/26/2024 |
STIM Neuronetics | $3.86
+3.2% | 3/26/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Neuronetics (NASDAQ:STIM) on 3/26/2024 |
AEHR Aehr Test Systems | $10.56
-0.3% | 3/25/2024 | Reiterated by | William Blair | Analyst J. Dorsheimer | Outperform -> Market Perform | | Low | View details for William Blair rating of Aehr Test Systems (NASDAQ:AEHR) on 3/25/2024 |
CUTR Cutera | $2.15
+10.8% | 3/22/2024 | Upgraded by | William Blair | - | Underperform -> Market Perform | | Low | View details for William Blair rating of Cutera (NASDAQ:CUTR) on 3/22/2024 |
NGNE Neurogene | $31.17
+1.8% | 3/21/2024 | Initiated by | William Blair | Analyst S. Corwin | Outperform | $61.00 | Low | View details for William Blair rating of Neurogene (NASDAQ:NGNE) on 3/21/2024 |
TPST Tempest Therapeutics | $3.42
+5.6% | 3/20/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Tempest Therapeutics (NASDAQ:TPST) on 3/20/2024 |
APPN Appian | $36.59
+4.2% | 3/20/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Appian (NASDAQ:APPN) on 3/20/2024 |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
CCL Carnival Co. & | $14.79
+3.6% | 3/19/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Carnival Co. & (NYSE:CCL) on 3/19/2024 |
FUSN Fusion Pharmaceuticals | $21.42
+0.5% | 3/19/2024 | Downgraded by | William Blair | Analyst A. Hsieh | Outperform -> Market Perform | | N/A | View details for William Blair rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/19/2024 |
SHCO Soho House & Co Inc. | $5.33
+0.8% | 3/18/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Soho House & Co Inc. (NYSE:SHCO) on 3/18/2024 |
MXCT MaxCyte | $3.80
-4.0% | 3/13/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of MaxCyte (NASDAQ:MXCT) on 3/13/2024 |
CLBT Cellebrite DI | $10.71
+2.3% | 3/13/2024 | Upgraded by | William Blair | - | Market Perform -> Outperform | | Low | View details for William Blair rating of Cellebrite DI (NASDAQ:CLBT) on 3/13/2024 |
PAR PAR Technology | $42.57
+3.6% | 3/12/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of PAR Technology (NYSE:PAR) on 3/12/2024 |
ZVRA Zevra Therapeutics | $4.58
+0.2% | 3/12/2024 | Reiterated by | William Blair | Analyst T. Lugo | Outperform | | Low | View details for William Blair rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/12/2024 |
ORCL Oracle | $115.07
+0.5% | 3/12/2024 | Upgraded by | William Blair | Analyst S. Naji | Market Perform -> Outperform | | Low | View details for William Blair rating of Oracle (NYSE:ORCL) on 3/12/2024 |
PBPB Potbelly | $10.86
+1.7% | 3/8/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Potbelly (NASDAQ:PBPB) on 3/8/2024 |
ARCT Arcturus Therapeutics | $27.93
+3.2% | 3/8/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/8/2024 |
HCI HCI Group | $114.73
+1.3% | 3/8/2024 | Upgraded by | William Blair | Analyst A. Klauber | Market Perform -> Outperform | | Low | View details for William Blair rating of HCI Group (NYSE:HCI) on 3/8/2024 |
CODI Compass Diversified | $23.22
+1.2% | 3/6/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Compass Diversified (NYSE:CODI) on 3/6/2024 |
MLNK MeridianLink | $18.00
+1.6% | 3/6/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of MeridianLink (NYSE:MLNK) on 3/6/2024 |
ALHC Alignment Healthcare | $5.18
+3.4% | 3/6/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Alignment Healthcare (NASDAQ:ALHC) on 3/6/2024 |
AVAV AeroVironment | $158.30
+5.7% | 3/5/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of AeroVironment (NASDAQ:AVAV) on 3/5/2024 |
MXCT MaxCyte | $3.80
-4.0% | 3/5/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of MaxCyte (NASDAQ:MXCT) on 3/5/2024 |
NKTR Nektar Therapeutics | $1.42
+4.4% | 3/5/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Nektar Therapeutics (NASDAQ:NKTR) on 3/5/2024 |
SMWB Similarweb | $7.89
+4.5% | 3/5/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Similarweb (NYSE:SMWB) on 3/5/2024 |
REKR Rekor Systems | $1.84
+2.8% | 3/4/2024 | Initiated by | William Blair | Analyst M. Pfau | Outperform | | Low | View details for William Blair rating of Rekor Systems (NASDAQ:REKR) on 3/4/2024 |
STER Sterling Check | $15.28
+1.0% | 3/1/2024 | Downgraded by | William Blair | Analyst A. Nicholas | Outperform -> Market Perform | | Low | View details for William Blair rating of Sterling Check (NASDAQ:STER) on 3/1/2024 |
ALKT Alkami Technology | $24.57
+2.5% | 2/29/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Alkami Technology (NASDAQ:ALKT) on 2/29/2024 |
KFY Korn Ferry | $63.22
+0.4% | 2/29/2024 | Upgraded by | William Blair | Analyst T. Romeo | Market Perform -> Outperform | | Low | View details for William Blair rating of Korn Ferry (NYSE:KFY) on 2/29/2024 |
KVYO Klaviyo | $23.38
+1.8% | 2/28/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Klaviyo (NYSE:KVYO) on 2/28/2024 |
ZETA Zeta Global | $12.12
+2.2% | 2/28/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Zeta Global (NASDAQ:ZETA) on 2/28/2024 |
TWKS Thoughtworks | $2.41
-0.8% | 2/28/2024 | Reiterated by | William Blair | Analyst M. Nolan | Outperform -> Market Perform | | Low | View details for William Blair rating of Thoughtworks (NASDAQ:TWKS) on 2/28/2024 |
FLYW Flywire | $21.41
+1.9% | 2/28/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Flywire (NASDAQ:FLYW) on 2/28/2024 |
CAVA CAVA Group | $61.22
+2.7% | 2/27/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of CAVA Group (NYSE:CAVA) on 2/27/2024 |
FGEN FibroGen | $1.07
-6.1% | 2/27/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of FibroGen (NASDAQ:FGEN) on 2/27/2024 |
JANX Janux Therapeutics | $49.78
+1.8% | 2/27/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Janux Therapeutics (NASDAQ:JANX) on 2/27/2024 |
KRYS Krystal Biotech | $162.04
+3.0% | 2/27/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Krystal Biotech (NASDAQ:KRYS) on 2/27/2024 |
ANRO Alto Neuroscience | $13.88
+1.8% | 2/27/2024 | Initiated by | William Blair | Analyst M. Minter | Outperform | | Low | View details for William Blair rating of Alto Neuroscience (NYSE:ANRO) on 2/27/2024 |
MLTX MoonLake Immunotherapeutics | $43.25
+5.4% | 2/26/2024 | Reiterated by | William Blair | - | Outperform | $92.00 | Low | View details for William Blair rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 2/26/2024 |
DVAX Dynavax Technologies | $11.76
-0.7% | 2/23/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Dynavax Technologies (NASDAQ:DVAX) on 2/23/2024 |
VCYT Veracyte | $19.83
-0.1% | 2/23/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Veracyte (NASDAQ:VCYT) on 2/23/2024 |
VKTX Viking Therapeutics | $64.93
+1.7% | 2/23/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Viking Therapeutics (NASDAQ:VKTX) on 2/23/2024 |
SQ Block | $75.21
+5.0% | 2/23/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Block (NYSE:SQ) on 2/23/2024 |
CVNA Carvana | $75.60
+5.8% | 2/23/2024 | Upgraded by | William Blair | Analyst S. Zackfia | Market Perform -> Outperform | | Low | View details for William Blair rating of Carvana (NYSE:CVNA) on 2/23/2024 |
EXAS Exact Sciences | $63.53
+1.8% | 2/22/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 2/22/2024 |
BROS Dutch Bros | $28.80
| 2/22/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Dutch Bros (NYSE:BROS) on 2/22/2024 |
KNTE Kinnate Biopharma | $2.65
-0.4% | 2/16/2024 | Downgraded by | William Blair | Analyst T. Lugo | Outperform -> Market Perform | | Low | View details for William Blair rating of Kinnate Biopharma (NASDAQ:KNTE) on 2/16/2024 |
NEO NeoGenomics | $14.16
+5.5% | 2/21/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of NeoGenomics (NASDAQ:NEO) on 2/21/2024 |
KROS Keros Therapeutics | $55.19
-1.1% | 2/21/2024 | Reiterated by | William Blair | Analyst M. Phipps | Outperform | | Low | View details for William Blair rating of Keros Therapeutics (NASDAQ:KROS) on 2/21/2024 |
SPRY ARS Pharmaceuticals | $8.50
+3.5% | 2/20/2024 | Upgraded by | William Blair | Analyst T. Lugo | Market Perform -> Outperform | | Low | View details for William Blair rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 2/20/2024 |
HSTM HealthStream | $26.41
+9.5% | 2/20/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of HealthStream (NASDAQ:HSTM) on 2/20/2024 |
APPN Appian | $36.59
+4.2% | 2/16/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Appian (NASDAQ:APPN) on 2/16/2024 |
DDOG Datadog | $126.44
+3.6% | 2/16/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Datadog (NASDAQ:DDOG) on 2/16/2024 |
IRDM Iridium Communications | $28.74
+2.2% | 2/15/2024 | Downgraded by | William Blair | Analyst L. Dipalma | Outperform -> Market Perform | | Low | View details for William Blair rating of Iridium Communications (NASDAQ:IRDM) on 2/15/2024 |
HUBS HubSpot | $651.77
+3.0% | 2/15/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of HubSpot (NYSE:HUBS) on 2/15/2024 |
SMWB Similarweb | $7.89
+4.5% | 2/15/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Similarweb (NYSE:SMWB) on 2/15/2024 |
INGN Inogen | $6.90
+3.0% | 2/15/2024 | Upgraded by | William Blair | Analyst M. Kaczor | Market Perform -> Outperform | | Low | View details for William Blair rating of Inogen (NASDAQ:INGN) on 2/15/2024 |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
QDEL QuidelOrtho | $40.40
+3.4% | 2/14/2024 | Reiterated by | William Blair | Analyst A. Brackmann | Outperform -> Market Perform | | Low | View details for William Blair rating of QuidelOrtho (NASDAQ:QDEL) on 2/14/2024 |
BL BlackLine | $61.46
+5.3% | 2/14/2024 | Downgraded by | William Blair | Analyst M. Pfau | Outperform -> Market Perform | | Low | View details for William Blair rating of BlackLine (NASDAQ:BL) on 2/14/2024 |
WEX WEX | $234.00
+1.5% | 2/8/2024 | Reiterated by | William Blair | Analyst C. Kennedy | Outperform | | Low | View details for William Blair rating of WEX (NYSE:WEX) on 2/8/2024 |
PYPL PayPal | $64.43
+2.0% | 2/8/2024 | Reiterated by | William Blair | Analyst C. Kennedy | Outperform | | Low | View details for William Blair rating of PayPal (NASDAQ:PYPL) on 2/8/2024 |
CBAY CymaBay Therapeutics | $32.48
| 2/12/2024 | Downgraded by | William Blair | Analyst A. Hsieh | Outperform -> Market Perform | | Low | View details for William Blair rating of CymaBay Therapeutics (NASDAQ:CBAY) on 2/12/2024 |
MSI Motorola Solutions | $345.69
+0.1% | 2/9/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Motorola Solutions (NYSE:MSI) on 2/9/2024 |
EHC Encompass Health | $82.46
+2.7% | 2/7/2024 | Reiterated by | William Blair | Analyst J. Haase | Outperform | | Low | View details for William Blair rating of Encompass Health (NYSE:EHC) on 2/7/2024 |
NVST Envista | $20.23
+0.6% | 2/8/2024 | Downgraded by | William Blair | Analyst B. Vazquez | Outperform -> Market Perform | | Low | View details for William Blair rating of Envista (NYSE:NVST) on 2/8/2024 |
JKHY Jack Henry & Associates | $166.48
+1.0% | 2/7/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Jack Henry & Associates (NASDAQ:JKHY) on 2/7/2024 |
WU Western Union | $13.39
+0.7% | 2/7/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Western Union (NYSE:WU) on 2/7/2024 |
SYM Symbotic | $40.25
+1.5% | 2/6/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Symbotic (NASDAQ:SYM) on 2/6/2024 |
INCY Incyte | $51.65
-0.5% | 2/6/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Incyte (NASDAQ:INCY) on 2/6/2024 |
VRTX Vertex Pharmaceuticals | $404.91
+1.2% | 2/6/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/6/2024 |
EVBG Everbridge | $34.90
+0.0% | 2/5/2024 | Downgraded by | William Blair | Analyst A. Bhatia | Outperform -> Market Perform | | Low | View details for William Blair rating of Everbridge (NASDAQ:EVBG) on 2/5/2024 |
ADUS Addus HomeCare | $94.76
+1.4% | 2/5/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Addus HomeCare (NASDAQ:ADUS) on 2/5/2024 |
MA Mastercard | $462.62
+1.3% | 1/31/2024 | Reiterated by | William Blair | Analyst C. Kennedy | Outperform | | Low | View details for William Blair rating of Mastercard (NYSE:MA) on 1/31/2024 |
LESL Leslie's | $4.57
+2.5% | 2/2/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Leslie’s (NASDAQ:LESL) on 2/2/2024 |
HOLX Hologic | $77.19
+1.3% | 2/2/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Hologic (NASDAQ:HOLX) on 2/2/2024 |
TEAM Atlassian | $199.44
+2.7% | 2/2/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Atlassian (NASDAQ:TEAM) on 2/2/2024 |
COUR Coursera | $12.12
-1.0% | 2/2/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Coursera (NYSE:COUR) on 2/2/2024 |
CHKP Check Point Software Technologies | $160.80
+1.3% | 1/31/2024 | Upgraded by | William Blair | - | Market Perform -> Outperform | | Low | View details for William Blair rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/31/2024 |
ABBV AbbVie | $169.54
+1.0% | 1/29/2024 | Upgraded by | William Blair | Analyst T. Lugo | Market Perform -> Outperform | | Low | View details for William Blair rating of AbbVie (NYSE:ABBV) on 1/29/2024 |
AIR AAR | $67.75
+2.3% | 1/29/2024 | Initiated by | William Blair | Analyst L. Dipalma | Outperform | | Low | View details for William Blair rating of AAR (NYSE:AIR) on 1/29/2024 |
V Visa | $274.23
+0.7% | 1/26/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Visa (NYSE:V) on 1/26/2024 |
EXEL Exelixis | $23.29
+1.8% | 1/26/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Exelixis (NASDAQ:EXEL) on 1/26/2024 |
MKTX MarketAxess | $204.77
+0.2% | 1/23/2024 | Reiterated by | William Blair | Analyst J. Schmitt | Outperform | | Low | View details for William Blair rating of MarketAxess (NASDAQ:MKTX) on 1/23/2024 |
COCO Vita Coco | $23.61
+2.3% | 1/22/2024 | Downgraded by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of Vita Coco (NASDAQ:COCO) on 1/22/2024 |
NTNX Nutanix | $61.07
+2.0% | 1/17/2024 | Upgraded by | William Blair | Analyst J. Ader | Market Perform -> Outperform | | Low | View details for William Blair rating of Nutanix (NASDAQ:NTNX) on 1/17/2024 |
ASGN ASGN | $100.73
+1.1% | 12/1/2023 | Initiated by | William Blair | Analyst M. Nolan | Buy -> Buy | | Low | View details for William Blair rating of ASGN (NYSE:ASGN) on 12/1/2023 |
BIIB Biogen | $193.18
-0.5% | 1/10/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Biogen (NASDAQ:BIIB) on 1/10/2024 |
ACCD Accolade | $9.35
+1.5% | 1/9/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Accolade (NASDAQ:ACCD) on 1/9/2024 |
BLUE bluebird bio | $0.97
+2.1% | 1/9/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of bluebird bio (NASDAQ:BLUE) on 1/9/2024 |
EVH Evolent Health | $30.13
+0.9% | 1/9/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Evolent Health (NYSE:EVH) on 1/9/2024 |
MXCT MaxCyte | $3.80
-4.0% | 1/9/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of MaxCyte (NASDAQ:MXCT) on 1/9/2024 |
U Unity Software | $23.10
+0.9% | 1/9/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Unity Software (NYSE:U) on 1/9/2024 |
DTC Solo Brands | $1.90
+3.8% | 1/8/2024 | Downgraded by | William Blair | Analyst P. Blee | Outperform -> Market Perform | | Low | View details for William Blair rating of Solo Brands (NYSE:DTC) on 1/8/2024 |
MAN ManpowerGroup | $76.44
+1.0% | 1/8/2024 | Initiated by | William Blair | Analyst T. Mchugh | Market Perform | | Low | View details for William Blair rating of ManpowerGroup (NYSE:MAN) on 1/8/2024 |
ALNY Alnylam Pharmaceuticals | $146.07
+0.2% | 1/8/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 1/8/2024 |
BRNS Barinthus Biotherapeutics | $2.60
-0.8% | 1/8/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 1/8/2024 |
EXAS Exact Sciences | $63.53
+1.8% | 1/8/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 1/8/2024 |
BECN Beacon Roofing Supply | $97.55
+1.6% | 1/8/2024 | Upgraded by | William Blair | Analyst R. Merkel | Market Perform -> Outperform | | Low | View details for William Blair rating of Beacon Roofing Supply (NASDAQ:BECN) on 1/8/2024 |
EXEL Exelixis | $23.29
+1.8% | 1/8/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Exelixis (NASDAQ:EXEL) on 1/8/2024 |
HOLX Hologic | $77.19
+1.3% | 1/8/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Hologic (NASDAQ:HOLX) on 1/8/2024 |
IDXX IDEXX Laboratories | $493.80
+3.0% | 1/5/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of IDEXX Laboratories (NASDAQ:IDXX) on 1/5/2024 |
FUSN Fusion Pharmaceuticals | $21.42
+0.5% | 1/5/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 1/5/2024 |
FTRE Fortrea | $36.94
+4.0% | 1/5/2024 | Initiated by | William Blair | Analyst M. Smock | Market Perform | | Low | View details for William Blair rating of Fortrea (NASDAQ:FTRE) on 1/5/2024 |
ENOV Enovis | $55.47
-0.1% | 1/3/2024 | Initiated by | William Blair | Analyst B. Vazquez | Outperform | | Low | View details for William Blair rating of Enovis (NYSE:ENOV) on 1/3/2024 |
PATH UiPath | $19.54
+3.4% | 1/2/2024 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of UiPath (NYSE:PATH) on 1/2/2024 |
KRTX Karuna Therapeutics | $329.83
| 12/22/2023 | Downgraded by | William Blair | Analyst M. Minter | Outperform -> Market Perform | | Low | View details for William Blair rating of Karuna Therapeutics (NASDAQ:KRTX) on 12/22/2023 |
JILL J.Jill | $26.13
+4.2% | 12/21/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of J.Jill (NYSE:JILL) on 12/21/2023 |
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (Ad) Big Banks have declared war on your wallet.
But it's not too late to fight back. Discover how to protect your assets from their latest maneuver. Learn More Now |
ARGX argenx | $375.08
+1.7% | 12/20/2023 | Downgraded by | William Blair | Analyst M. Minter | Outperform -> Market Perform | | Low | View details for William Blair rating of argenx (NASDAQ:ARGX) on 12/20/2023 |
LNTH Lantheus | $64.41
+2.1% | 12/18/2023 | Downgraded by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of Lantheus (NASDAQ:LNTH) on 12/18/2023 |
SES SES AI | $1.29
+12.2% | 12/18/2023 | Initiated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of SES AI (NYSE:SES) on 12/18/2023 |
QS QuantumScape | $5.59
+3.7% | 12/18/2023 | Initiated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of QuantumScape (NYSE:QS) on 12/18/2023 |
ENVX Enovix | $6.03
+0.8% | 12/18/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Enovix (NASDAQ:ENVX) on 12/18/2023 |
AMPX Amprius Technologies | $1.75
+3.6% | 12/18/2023 | Initiated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Amprius Technologies (NYSE:AMPX) on 12/18/2023 |
ALLK Allakos | $1.05
-0.9% | 12/18/2023 | Upgraded by | William Blair | Analyst T. Lugo | Market Perform -> Outperform | | Low | View details for William Blair rating of Allakos (NASDAQ:ALLK) on 12/18/2023 |
RPHM Reneo Pharmaceuticals | $1.68
-0.6% | 12/14/2023 | Downgraded by | William Blair | Analyst M. Minter | Outperform -> Market Perform | | N/A | View details for William Blair rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 12/14/2023 |
HRT HireRight | $14.34
+0.1% | 12/11/2023 | Downgraded by | William Blair | Analyst A. Nicholas | Outperform -> Market Perform | | Low | View details for William Blair rating of HireRight (NYSE:HRT) on 12/11/2023 |
AAP Advance Auto Parts | $78.01
+1.0% | 12/13/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Advance Auto Parts (NYSE:AAP) on 12/13/2023 |
AZO AutoZone | $2,961.04
0.0% | 12/13/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of AutoZone (NYSE:AZO) on 12/13/2023 |
TDG TransDigm Group | $1,241.95
+3.4% | 12/12/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of TransDigm Group (NYSE:TDG) on 12/12/2023 |
HEI HEICO | $204.80
+2.7% | 12/12/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of HEICO (NYSE:HEI) on 12/12/2023 |
BA Boeing | $169.17
-0.8% | 12/12/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Boeing (NYSE:BA) on 12/12/2023 |
VTGN Vistagen Therapeutics | $4.83
+1.0% | 12/4/2023 | Reiterated by | William Blair | Analyst T. Lugo | Outperform | | Low | View details for William Blair rating of Vistagen Therapeutics (NASDAQ:VTGN) on 12/4/2023 |
CABA Cabaletta Bio | $13.32
| 11/29/2023 | Reiterated by | William Blair | Analyst S. Corwin | Outperform | $38.00 | Low | View details for William Blair rating of Cabaletta Bio (NASDAQ:CABA) on 11/29/2023 |
NAMS NewAmsterdam Pharma | $21.45
+6.0% | 11/22/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 11/22/2023 |
DV DoubleVerify | $30.50
+2.9% | 11/22/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of DoubleVerify (NYSE:DV) on 11/22/2023 |
CVNA Carvana | $75.60
+5.8% | 11/17/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Carvana (NYSE:CVNA) on 11/17/2023 |
IKNA Ikena Oncology | $1.35
+3.8% | 11/16/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Ikena Oncology (NASDAQ:IKNA) on 11/16/2023 |
ARCT Arcturus Therapeutics | $27.93
+3.2% | 11/15/2023 | Reiterated by | William Blair | Analyst M. Minter | Outperform | | Low | View details for William Blair rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/15/2023 |
AUTL Autolus Therapeutics | $4.48
-1.8% | 11/15/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Autolus Therapeutics (NASDAQ:AUTL) on 11/15/2023 |
EVBG Everbridge | $34.90
+0.0% | 11/10/2023 | Reiterated by | William Blair | Analyst A. Bhatia | Outperform | | Low | View details for William Blair rating of Everbridge (NASDAQ:EVBG) on 11/10/2023 |
RPHM Reneo Pharmaceuticals | $1.68
-0.6% | 11/15/2023 | Initiated by | William Blair | - | Outperform | $35.55 | Low | View details for William Blair rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 11/15/2023 |
RGNX REGENXBIO | $15.90
+1.7% | 11/14/2023 | Reiterated by | William Blair | - | Neutral | $20.00 -> $21.00 | Low | View details for William Blair rating of REGENXBIO (NASDAQ:RGNX) on 11/14/2023 |
CTLT Catalent | $56.01
-0.1% | 11/14/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Catalent (NYSE:CTLT) on 11/14/2023 |
CBAY CymaBay Therapeutics | $32.48
| 11/14/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of CymaBay Therapeutics (NASDAQ:CBAY) on 11/14/2023 |
XGN Exagen | $1.37
-2.1% | 11/14/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Exagen (NASDAQ:XGN) on 11/14/2023 |
ZETA Zeta Global | $12.12
+2.2% | 11/14/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Zeta Global (NASDAQ:ZETA) on 11/14/2023 |
SKIN Beauty Health | $3.22
-1.5% | 11/14/2023 | Downgraded by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of Beauty Health (NASDAQ:SKIN) on 11/14/2023 |
VERX Vertex | $27.94
-7.0% | 11/9/2023 | Reiterated by | William Blair | Analyst M. Pfau | Outperform | | Low | View details for William Blair rating of Vertex (NASDAQ:VERX) on 11/9/2023 |
TWLO Twilio | $60.33
+2.9% | 11/9/2023 | Reiterated by | William Blair | Analyst A. Bhatia | Outperform | | Low | View details for William Blair rating of Twilio (NYSE:TWLO) on 11/9/2023 |
VERV Verve Therapeutics | $6.88
-0.4% | 11/13/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Verve Therapeutics (NASDAQ:VERV) on 11/13/2023 |
IONS Ionis Pharmaceuticals | $41.84
+1.9% | 11/13/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 11/13/2023 |
ACRS Aclaris Therapeutics | $1.22
| 11/13/2023 | Downgraded by | William Blair | Analyst T. Lugo | Outperform -> Market Perform | | N/A | View details for William Blair rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/13/2023 |
ADPT Adaptive Biotechnologies | $2.58
+2.8% | 11/10/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 11/10/2023 |
BRNS Barinthus Biotherapeutics | $2.60
-0.8% | 11/10/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 11/10/2023 |
GBIO Generation Bio | $3.26
+16.0% | 11/10/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Generation Bio (NASDAQ:GBIO) on 11/10/2023 |
HOLX Hologic | $77.19
+1.3% | 11/10/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Hologic (NASDAQ:HOLX) on 11/10/2023 |
IRDM Iridium Communications | $28.74
+2.2% | 11/10/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Iridium Communications (NASDAQ:IRDM) on 11/10/2023 |
XRAY DENTSPLY SIRONA | $30.86
+1.6% | 11/10/2023 | Upgraded by | William Blair | Analyst B. Vazquez | Market Perform -> Outperform | | Low | View details for William Blair rating of DENTSPLY SIRONA (NASDAQ:XRAY) on 11/10/2023 |
HUBS HubSpot | $651.77
+3.0% | 11/9/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of HubSpot (NYSE:HUBS) on 11/9/2023 |
JAMF Jamf | $19.27
+0.6% | 11/9/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Jamf (NASDAQ:JAMF) on 11/9/2023 |
BIIB Biogen | $193.18
-0.5% | 11/9/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Biogen (NASDAQ:BIIB) on 11/9/2023 |
MXCT MaxCyte | $3.80
-4.0% | 11/9/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of MaxCyte (NASDAQ:MXCT) on 11/9/2023 |
SCTL Societal CDMO | $1.10
+0.9% | 11/9/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Societal CDMO (NASDAQ:SCTL) on 11/9/2023 |
SERA Sera Prognostics | $9.96
+1.9% | 11/9/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Sera Prognostics (NASDAQ:SERA) on 11/9/2023 |
RNG RingCentral | $30.54
+3.5% | 11/7/2023 | Reiterated by | William Blair | Analyst A. Bhatia | Outperform | | Low | View details for William Blair rating of RingCentral (NYSE:RNG) on 11/7/2023 |
BBAI BigBear.ai | $1.71
+9.6% | 11/8/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of BigBear.ai (NYSE:BBAI) on 11/8/2023 |
BLND Blend Labs | $2.49
+4.2% | 11/8/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Blend Labs (NYSE:BLND) on 11/8/2023 |
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (Ad) Big Banks have declared war on your wallet.
But it's not too late to fight back. Discover how to protect your assets from their latest maneuver. Learn More Now |
DDOG Datadog | $126.44
+3.6% | 11/8/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Datadog (NASDAQ:DDOG) on 11/8/2023 |
PWSC PowerSchool | $17.67
+1.1% | 11/8/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of PowerSchool (NYSE:PWSC) on 11/8/2023 |
BDSX Biodesix | $1.28
-0.8% | 11/8/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Biodesix (NASDAQ:BDSX) on 11/8/2023 |
JSPR Jasper Therapeutics | $22.11
-1.8% | 11/8/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Jasper Therapeutics (NASDAQ:JSPR) on 11/8/2023 |
PYXS Pyxis Oncology | $4.50
-0.7% | 11/8/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Pyxis Oncology (NASDAQ:PYXS) on 11/8/2023 |
VCYT Veracyte | $19.83
-0.1% | 11/8/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Veracyte (NASDAQ:VCYT) on 11/8/2023 |
FLYW Flywire | $21.41
+1.9% | 11/8/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Flywire (NASDAQ:FLYW) on 11/8/2023 |
MQ Marqeta | $5.65
+4.1% | 11/8/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Marqeta (NASDAQ:MQ) on 11/8/2023 |
CAVA CAVA Group | $61.22
+2.7% | 11/8/2023 | Reiterated by | William Blair | Analyst S. Zackfia | Outperform | | Low | View details for William Blair rating of CAVA Group (NYSE:CAVA) on 11/8/2023 |
FIVN Five9 | $60.14
+3.2% | 11/3/2023 | Reiterated by | William Blair | Analyst A. Bhatia | Outperform | | Low | View details for William Blair rating of Five9 (NASDAQ:FIVN) on 11/3/2023 |
BAND Bandwidth | $18.15
+3.5% | 11/3/2023 | Reiterated by | William Blair | Analyst A. Bhatia | Outperform | | Low | View details for William Blair rating of Bandwidth (NASDAQ:BAND) on 11/3/2023 |
ANSS ANSYS | $325.97
+0.4% | 11/2/2023 | Reiterated by | William Blair | Analyst D. Becker | Market Perform | | Low | View details for William Blair rating of ANSYS (NASDAQ:ANSS) on 11/2/2023 |
OLO OLO | $4.92
+4.5% | 11/7/2023 | Downgraded by | William Blair | Analyst S. Sheldon | Outperform -> Market Perform | | Low | View details for William Blair rating of OLO (NYSE:OLO) on 11/7/2023 |
AMRC Ameresco | $20.87
+9.3% | 11/7/2023 | Downgraded by | William Blair | Analyst T. Mulrooney | Outperform -> Market Perform | | Low | View details for William Blair rating of Ameresco (NYSE:AMRC) on 11/7/2023 |
SBUX Starbucks | $87.87
-0.4% | 11/6/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Starbucks (NASDAQ:SBUX) on 11/6/2023 |
ARCT Arcturus Therapeutics | $27.93
+3.2% | 11/6/2023 | Reiterated by | William Blair | Analyst M. Minter | Outperform | | Low | View details for William Blair rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/6/2023 |
BIRK Birkenstock | $44.84
+2.1% | 11/6/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Birkenstock (NYSE:BIRK) on 11/6/2023 |
ENS EnerSys | $91.07
+1.1% | 11/6/2023 | Downgraded by | William Blair | Analyst B. Drab | Outperform -> Market Perform | | Low | View details for William Blair rating of EnerSys (NYSE:ENS) on 11/6/2023 |
FTNT Fortinet | $64.80
+1.7% | 11/3/2023 | Downgraded by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of Fortinet (NASDAQ:FTNT) on 11/3/2023 |
BILL BILL | $61.27
+1.1% | 11/3/2023 | Downgraded by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of BILL (NYSE:BILL) on 11/3/2023 |
ZETA Zeta Global | $12.12
+2.2% | 11/2/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Zeta Global (NASDAQ:ZETA) on 11/2/2023 |
EXAS Exact Sciences | $63.53
+1.8% | 11/2/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 11/2/2023 |
GBIO Generation Bio | $3.26
+16.0% | 11/2/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Generation Bio (NASDAQ:GBIO) on 11/2/2023 |
QDEL QuidelOrtho | $40.40
+3.4% | 11/2/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of QuidelOrtho (NASDAQ:QDEL) on 11/2/2023 |
CAKE Cheesecake Factory | $35.48
+3.4% | 11/2/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Cheesecake Factory (NASDAQ:CAKE) on 11/2/2023 |
ALKT Alkami Technology | $24.57
+2.5% | 11/2/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Alkami Technology (NASDAQ:ALKT) on 11/2/2023 |
PYPL PayPal | $64.43
+2.0% | 11/2/2023 | Reiterated by | William Blair | Analyst R. Napoli | Outperform | | Low | View details for William Blair rating of PayPal (NASDAQ:PYPL) on 11/2/2023 |
EYEN Eyenovia | $0.54
+5.9% | 11/1/2023 | Reiterated by | William Blair | Analyst T. Lugo | Outperform | | Low | View details for William Blair rating of Eyenovia (NASDAQ:EYEN) on 11/1/2023 |
PAYC Paycom Software | $188.09
+0.7% | 11/1/2023 | Downgraded by | William Blair | Analyst M. Pfau | Outperform -> Market Perform | | Low | View details for William Blair rating of Paycom Software (NYSE:PAYC) on 11/1/2023 |
BEAM Beam Therapeutics | $23.47
-2.6% | 10/31/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Beam Therapeutics (NASDAQ:BEAM) on 10/31/2023 |
CTLT Catalent | $56.01
-0.1% | 10/31/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Catalent (NYSE:CTLT) on 10/31/2023 |
ANET Arista Networks | $251.28
+2.4% | 10/31/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Arista Networks (NYSE:ANET) on 10/31/2023 |
VRNS Varonis Systems | $44.79
+1.7% | 10/31/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Varonis Systems (NASDAQ:VRNS) on 10/31/2023 |
BMY Bristol-Myers Squibb | $49.00
-0.3% | 10/27/2023 | Downgraded by | William Blair | Analyst M. Phipps | Outperform -> Market Perform | | Low | View details for William Blair rating of Bristol-Myers Squibb (NYSE:BMY) on 10/27/2023 |
WU Western Union | $13.39
+0.7% | 10/26/2023 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Western Union (NYSE:WU) on 10/26/2023 |
BIIB Biogen | $193.18
-0.5% | 10/26/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Biogen (NASDAQ:BIIB) on 10/26/2023 |
NOW ServiceNow | $740.95
+2.6% | 10/26/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of ServiceNow (NYSE:NOW) on 10/26/2023 |
SEE Sealed Air | $31.49
-0.5% | 10/24/2023 | Downgraded by | William Blair | Analyst L. De. Maria | Outperform -> Market Perform | | Low | View details for William Blair rating of Sealed Air (NYSE:SEE) on 10/24/2023 |
MKFG Markforged | $0.68
+1.5% | 10/24/2023 | Downgraded by | William Blair | Analyst B. Drab | Outperform -> Market Perform | | Low | View details for William Blair rating of Markforged (NYSE:MKFG) on 10/24/2023 |
EXEL Exelixis | $23.29
+1.8% | 10/23/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Exelixis (NASDAQ:EXEL) on 10/23/2023 |
CELH Celsius | $72.03
+3.2% | 10/23/2023 | Initiated by | William Blair | Analyst J. Andersen | Outperform | | Low | View details for William Blair rating of Celsius (NASDAQ:CELH) on 10/23/2023 |
KVYO Klaviyo | $23.38
+1.8% | 10/16/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Klaviyo (NYSE:KVYO) on 10/16/2023 |
HCP HashiCorp | $29.15
+18.7% | 10/12/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of HashiCorp (NASDAQ:HCP) on 10/12/2023 |
NMRA Neumora Therapeutics | $10.30
-1.1% | 10/10/2023 | Initiated by | William Blair | Analyst M. Minter | Outperform -> Outperform | $26.00 | Low | View details for William Blair rating of Neumora Therapeutics (NASDAQ:NMRA) on 10/10/2023 |
SP SP Plus | $50.78
+1.1% | 10/5/2023 | Downgraded by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of SP Plus (NASDAQ:SP) on 10/5/2023 |
MXCT MaxCyte | $3.80
-4.0% | 10/5/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of MaxCyte (NASDAQ:MXCT) on 10/5/2023 |
CCL Carnival Co. & | $14.79
+3.6% | 10/2/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Carnival Co. & (NYSE:CCL) on 10/2/2023 |
NCNO nCino | $30.16
+1.8% | 9/29/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of nCino (NASDAQ:NCNO) on 9/29/2023 |
FNA Paragon 28 | $10.05
+2.7% | 9/29/2023 | Initiated by | William Blair | Analyst B. Vazquez | Outperform | | Low | View details for William Blair rating of Paragon 28 (NYSE:FNA) on 9/29/2023 |
LNTH Lantheus | $64.41
+2.1% | 9/29/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Lantheus (NASDAQ:LNTH) on 9/29/2023 |
LULU Lululemon Athletica | $364.68
+0.8% | 9/28/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Lululemon Athletica (NASDAQ:LULU) on 9/28/2023 |
CFLT Confluent | $28.53
+4.3% | 9/28/2023 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Confluent (NASDAQ:CFLT) on 9/28/2023 |
CDMO Avid Bioservices | $6.68
+4.2% | 9/28/2023 | Initiated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Avid Bioservices (NASDAQ:CDMO) on 9/28/2023 |
SN SharkNinja | 62.55
+1.1% | 9/26/2023 | Initiated by | William Blair | - | Outperform | | Low | View details for William Blair rating of SharkNinja (NYSE:SN) on 9/26/2023 |
TVTX Travere Therapeutics | $5.74
-1.9% | 9/21/2023 | Downgraded by | William Blair | Analyst T. Lugo | Outperform -> Market Perform | | Low | View details for William Blair rating of Travere Therapeutics (NASDAQ:TVTX) on 9/21/2023 |
SPLK Splunk | $156.90
| 9/21/2023 | Downgraded by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of Splunk (NASDAQ:SPLK) on 9/21/2023 |
SPRY ARS Pharmaceuticals | $8.50
+3.5% | 9/20/2023 | Downgraded by | William Blair | Analyst T. Lugo | Outperform -> Market Perform | | Low | View details for William Blair rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 9/20/2023 |
NTAP NetApp | $99.42
+1.5% | 9/18/2023 | Downgraded by | William Blair | Analyst J. Ader | Outperform -> Market Perform | | Low | View details for William Blair rating of NetApp (NASDAQ:NTAP) on 9/18/2023 |
DBX Dropbox | $23.47
+0.7% | 9/18/2023 | Downgraded by | William Blair | Analyst J. Ader | Outperform -> Market Perform | | Low | View details for William Blair rating of Dropbox (NASDAQ:DBX) on 9/18/2023 |
FROG JFrog | $39.17
+3.8% | 9/14/2023 | Upgraded by | William Blair | Analyst J. Ader | Market Perform -> Outperform | | Low | View details for William Blair rating of JFrog (NASDAQ:FROG) on 9/14/2023 |
